Page last updated: 2024-08-21

adamantane and ATLL

adamantane has been researched along with ATLL in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Darwiche, N; Dbaibo, G; Ghandour, B; Pisano, C1
Abdel-Samad, R; Bazarbachi, A; Darwiche, N; Dbaibo, G; El Hajj, H; Ghandour, B; Ghantous, A; Hall, WW; Hasegawa, H; Jabbour, M; Khalil, B; Nasr, R; Pisano, C; Shahine, S; Sinjab, A; Zaatari, G1
Césaire, R; Meniane, JC1
Avramis, IA; Avramis, VI; Laug, WE; Sausville, EA1

Other Studies

4 other study(ies) available for adamantane and ATLL

ArticleYear
Restoration of ceramide de novo synthesis by the synthetic retinoid ST1926 as it induces adult T-cell leukemia cell death.
    Bioscience reports, 2020, 10-30, Volume: 40, Issue:10

    Topics: Adamantane; Antineoplastic Agents; Cell Death; Ceramides; Cinnamates; Enzyme Activation; Gene Products, tax; Human T-lymphotropic virus 1; Humans; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Oxidoreductases; Proteolysis; Proto-Oncogene Proteins c-bcl-2; Time Factors

2020
Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphoma.
    Blood, 2014, Sep-25, Volume: 124, Issue:13

    Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Transformed; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cinnamates; Disease Models, Animal; DNA Damage; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Gene Products, tax; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemic Infiltration; Mice; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2014
ST1926 repression of Tax: ATL targeted treatment?
    Blood, 2014, Sep-25, Volume: 124, Issue:13

    Topics: Adamantane; Animals; Antineoplastic Agents; Cinnamates; Humans; Leukemia-Lymphoma, Adult T-Cell

2014
Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
    Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:4

    Topics: Adamantane; Antimetabolites, Antineoplastic; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cytarabine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Hydroquinones; Imatinib Mesylate; Leukemia-Lymphoma, Adult T-Cell; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Vascular Endothelial Growth Factor A; Vidarabine Phosphate

2003